Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study
about
Platinum-induced hearing loss after treatment for childhood cancerBone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review.Role of High-dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Ewing's Sarcoma: A Case Report with Focused Review of Literature.
P2860
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study
description
im September 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2014
@uk
name
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@en
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@nl
type
label
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@en
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@nl
prefLabel
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@en
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@nl
P2093
P2860
P356
P1476
Etoposide and carbo-or cisplat ...... a: A large retrospective study
@en
P2093
Annemiek M. van Maldegem
Charlotte Benson
Hans Gelderblom
Henk van den Berg
Heribert Juergens
Ian Judson
Joanna Placzke
Meybrit Rasper
Uta Dirksen
P2860
P356
10.1002/PBC.25230
P577
2014-09-22T00:00:00Z